These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 33527211)

  • 1. COVID-19-associated liver injury: from bedside to bench.
    Li D; Ding X; Xie M; Tian D; Xia L
    J Gastroenterol; 2021 Mar; 56(3):218-230. PubMed ID: 33527211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic complications of COVID-19 and its treatment.
    Tian D; Ye Q
    J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
    Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
    Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Mechanisms Behind Adverse Effect of Coronavirus Disease-19 on Heart and Liver Damage: A Review.
    Daba TM; Mokonon M; Niguse E; Getahun M
    Ethiop J Health Sci; 2024 Jan; 34(1):85-100. PubMed ID: 38957334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients.
    Naeem M; Bano N; Manzoor S; Ahmad A; Munawar N; Razak SIA; Lee TY; Devaraj S; Hazafa A
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.
    Perico L; Benigni A; Casiraghi F; Ng LFP; Renia L; Remuzzi G
    Nat Rev Nephrol; 2021 Jan; 17(1):46-64. PubMed ID: 33077917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
    Del Turco S; Vianello A; Ragusa R; Caselli C; Basta G
    Thromb Res; 2020 Dec; 196():143-151. PubMed ID: 32871306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver injury in COVID-19: Detection, pathogenesis, and treatment.
    Cai Y; Ye LP; Song YQ; Mao XL; Wang L; Jiang YZ; Que WT; Li SW
    World J Gastroenterol; 2021 Jun; 27(22):3022-3036. PubMed ID: 34168405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of COVID-19 on Liver Injury.
    Dawood DRM; Salum GM; El-Meguid MA
    Am J Med Sci; 2022 Feb; 363(2):94-103. PubMed ID: 34752738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Clinical and Pathological Findings of Liver Injury in 27 Patients With Lethal COVID-19 Infections in Brazil.
    Santana MF; Guerra MT; Hundt MA; Ciarleglio MM; Pinto RAA; Dutra BG; Xavier MS; Lacerda MVG; Ferreira AJ; Wanderley DC; Borges do Nascimento IJ; Araújo RFA; Pinheiro SVB; Araújo SA; Leite MF; Ferreira LCL; Nathanson MH; Vieira Teixeira Vidigal P
    Hepatol Commun; 2022 Feb; 6(2):270-280. PubMed ID: 34520633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications.
    Rodriguez-Espada A; Salgado-de la Mora M; Rodriguez-Paniagua BM; Limon-de la Rosa N; Martinez-Gutierrez MI; Pastrana-Brandes S; Navarro-Alvarez N
    World J Gastroenterol; 2024 Jun; 30(22):2866-2880. PubMed ID: 38947288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential mechanisms of cerebrovascular diseases in COVID-19 patients.
    Lou M; Yuan D; Liao S; Tong L; Li J
    J Neurovirol; 2021 Feb; 27(1):35-51. PubMed ID: 33534131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.